Skip to main content
OpenTrials

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

716 public trials 251 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumor trial results

Active, Not Recruiting

A Study of LY3200882 in Participants With Solid Tumors

NCT02937272

Conditions
Bone Diseases, Bone Diseases, Developmental, Camurati-Engelmann Syndrome, +5 more
Locations
  • University of Louisville Louisville, Kentucky, United States
  • Weill Cornell Medical College New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors

NCT04419532

Conditions
Advanced Cancer, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Cincinnati Cancer Center Cincinnati, Ohio, United States
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
  • National Cancer Center Hospital Chūōku, Japan
View Trial Details
Active, Not Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT06710847

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +26 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site New York, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

NCT05544552

Conditions
Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, +31 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • UMass Memorial Medical Center Worchester, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • Duke Cancer Institute (DCI) - Duke Cancer Center Durham, North Carolina, United States
View all 19 locations
View Trial Details

Related conditions